An interventional study of percutaneous coronary intervention and coronary artery bypass grafting in Coronary Disease and Cardiovascular Diseases, sponsored by Russian Cardiology Research and Production Center. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-08-05.
Sponsored by Russian Cardiology Research and Production Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to explore the role of lipoprotein(a) and apolipoprotein(a) phenotype in fatal and non-fatal cardiovascular disease (CVD) events risk in coronary disease patients divided on the basis of management strategy - medical, endovascular or open cardiac surgery.
Between January 1993 and September 2006, we enrolled 1400 consecutive patients from the Atherosclerosis Department with known Lp(a) levels and coronary heart disease (CHD) verified by angiography. In accordance with clinical condition and angiography data were assigned them into three parallel treatment arms and followed up to 15 years. This study was conducted according to the principles of the Declaration of Helsinki and the Institutional Ethics Committee.
1,522 studies on the registry are indexed under Coronary Disease; 167 are open to participants now.
This study's enrollment of 1,400 is above the median of 160 across 780 interventional studies indexed under Coronary Disease.
Browse Coronary Disease studies →Russian Cardiology Research and Production Center is the lead sponsor of 9 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Men and women with stable CHD verified by angiography from one center and allocated to three treatment arms in real-world practice: 1. conservative treatment with statins, antiaggregants, antianginal drugs in standard dosage
2. elective balloon angioplasty alone or stent implanation on the basement of drugs treatment
Procedure: percutaneous coronary intervention
elective surgery myocardial revascularisation on the basement of drugs treatment
Procedure: coronary artery bypass grafting
elective percutaneous coronary balloon angioplasty and/or stenting
elective surgical myocardial revascularisation
non-fatal myocardial infarction and cardiovascular death
we took a composite primary outcome measure because anticipated a low number of hard-end-points in each treatment arm
Time frame: up to 15 years
non-fatal myocardial infarction and cardiovascular death and myocardial revascularisation and hospitalization for recurrent or unstable angina
we chose a composite secondary outcome mesure as a standard for such type studies and to obtain a statistical difference between the groups
Time frame: up to 15 years
No study locations are listed for this record.
The record gives a start of Jan 1993, a primary completion of Sep 2006 and a completion of Jan 2014. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Russian Cardiology Research and Production Center